Skip to main content

Posts

White Matter Wonders: Re-imagining the Brain’s Silent Majority

Historically, scientific research has largely focused on the gray matter of the brain, leaving the equally important white matter understudied. However, a recent groundbreaking study has used fMRI to detect significant brain activity in white matter. from Neuroscience News https://ift.tt/a8wyYd7

Linking Sleep Deficits to Depression

Researchers find a connection between consistently sleeping less than five hours nightly and an increased risk of developing depressive symptoms. Initially believed that poor sleep was a mere side effect of mental illness, the study suggests sleep might precede the onset of depression. from Neuroscience News https://ift.tt/wQO2VKU

Dad’s Postpartum Depression: Hidden Risk for Childhood Adversities

Research reveals that a father's depression during a child's first year can lead to increased odds of the child experiencing multiple adverse events by age 5. Adverse childhood experiences have lasting impacts, including health and academic challenges. from Neuroscience News https://ift.tt/hQnMIuE

New Eye Clock Predicts Aging Through Fluid Proteins

Researchers have pioneered a method to measure ocular aging by studying proteins in eye fluid. Using artificial intelligence, they crafted an "eye-aging clock" from 26 out of nearly 6,000 proteins which can forecast aging. from Neuroscience News https://ift.tt/6O7Q8ME

Xanax’s Efficacy Questioned

Researchers have discovered discrepancies in the efficacy of alprazolam (Xanax XR), a widely prescribed benzodiazepine sedative, when analyzing both published and unpublished clinical trial data. The study found that only one of the five FDA-reviewed trials showed a clearly positive outcome. from Neuroscience News https://ift.tt/I6EgdaU

Does Drug Effect or Power of Belief Explain Ketamine’s Antidepressant Effect?

Researchers conducted a unique study to uncover the efficacy of ketamine in treating depression, bypassing its unmistakable psychedelic effects by administering it during surgery. Surprisingly, both the ketamine and placebo groups showed substantial improvement in depression symptoms. from Neuroscience News https://ift.tt/D5PIO0u